202 related articles for article (PubMed ID: 35677438)
1. Role of Licochalcone A in Potential Pharmacological Therapy: A Review.
Li MT; Xie L; Jiang HM; Huang Q; Tong RS; Li X; Xie X; Liu HM
Front Pharmacol; 2022; 13():878776. PubMed ID: 35677438
[TBL] [Abstract][Full Text] [Related]
2. Diosmetin as a promising natural therapeutic agent: In vivo, in vitro mechanisms, and clinical studies.
Sun Z; Liu K; Liang C; Wen L; Wu J; Liu X; Li X
Phytother Res; 2024 May; ():. PubMed ID: 38748620
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase-4 inhibitory potentials of
Shaikh S; Ali S; Lim JH; Chun HJ; Ahmad K; Ahmad SS; Hwang YC; Han KS; Kim NR; Lee EJ; Choi I
Front Mol Biosci; 2022; 9():1024764. PubMed ID: 36250007
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects of licochalcones: A review of the mechanisms.
Deng N; Qiao M; Li Y; Liang F; Li J; Liu Y
Front Pharmacol; 2023; 14():1074506. PubMed ID: 36755942
[TBL] [Abstract][Full Text] [Related]
5. Licochalcone A Derivatives as Selective Dipeptidyl Peptidase 4 Inhibitors with Anti-Inflammatory Effects.
Li CQ; Shi JH; Mu J; Wang AQ; Zou LW; Ge GB
J Nat Prod; 2023 Jul; 86(7):1824-1831. PubMed ID: 37337963
[TBL] [Abstract][Full Text] [Related]
6. Licochalcone A Exerts Anti-Cancer Activity by Inhibiting STAT3 in SKOV3 Human Ovarian Cancer Cells.
Seo J; Lee DE; Kim SM; Kim E; Kim JK
Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238935
[TBL] [Abstract][Full Text] [Related]
7. Licochalcone A Suppresses Renal Cancer Cell Proliferation and Metastasis by Engagement of Sp1-Mediated LC3 Expression.
Tseng TY; Lee CH; Lee HL; Su CY; Kao CY; Tsai JP; Hsieh YH
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840005
[TBL] [Abstract][Full Text] [Related]
8. Licochalcone A Inhibits Prostaglandin E
Bhatia HS; Apweiler M; Sun L; Baron J; Tirkey A; Fiebich BL
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838914
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of shaogan fuzi decoction in rheumatoid arthritis: Network pharmacology and experimental validation.
Shi L; Zhao Y; Feng C; Miao F; Dong L; Wang T; Stalin A; Zhang J; Tu J; Liu K; Sun W; Wu J
Front Pharmacol; 2022; 13():967164. PubMed ID: 36059943
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective potential of biochanin-A and review of the molecular mechanisms involved.
Singh L; Kaur N; Bhatti R
Mol Biol Rep; 2023 Jun; 50(6):5369-5378. PubMed ID: 37039995
[TBL] [Abstract][Full Text] [Related]
11. [Licochalcone A induces cell cycle arrest in human lung squamous carcinoma cells
Fan X; Wang J; Wang L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):111-116. PubMed ID: 36856218
[TBL] [Abstract][Full Text] [Related]
12. Chalcone-1-Deoxynojirimycin Heterozygote Reduced the Blood Glucose Concentration and Alleviated the Adverse Symptoms and Intestinal Flora Disorder of Diabetes Mellitus Rats.
Xiao PJ; Zeng JC; Lin P; Tang DB; Yuan E; Tu YG; Zhang QF; Chen JG; Peng DY; Yin ZP
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364410
[TBL] [Abstract][Full Text] [Related]
13. Prenylated Flavonoids in Topical Infections and Wound Healing.
Sychrová A; Škovranová G; Čulenová M; Bittner Fialová S
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889363
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of pruritus ani lotion combined with Huajiao-Gancao-Bingpian oil for pruritus ani treatment based on network pharmacology and molecular dynamics.
Deng W; Fu M; Huang J
Postepy Dermatol Alergol; 2024 Apr; 41(2):203-214. PubMed ID: 38784930
[TBL] [Abstract][Full Text] [Related]
15. Exploring the pharmacological mechanism of Glycyrrhiza uralensis against KOA through integrating network pharmacology and experimental assessment.
Xu J; Sun Q; Qiu M; Wu Y; Cheng L; Jiang N; Zhang R; Chen J; Yuan W; Jin H; Wang W; Cai Y; Zhang C; Wang P
J Cell Mol Med; 2024 May; 28(9):e18319. PubMed ID: 38742846
[TBL] [Abstract][Full Text] [Related]
16. Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles.
Hba S; Ghaddar S; Wahnou H; Pinon A; El Kebbaj R; Pouget C; Sol V; Liagre B; Oudghiri M; Limami Y
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140059
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology integrated with experimental verification reveals the antipyretic characteristics and mechanism of Zi Xue powder.
Zhang H; Ge S; Diao F; Song W; Zhang Y; Zhuang P; Zhang Y
Pharm Biol; 2023 Dec; 61(1):1512-1524. PubMed ID: 38069658
[TBL] [Abstract][Full Text] [Related]
18. Bioactive nutraceuticals as G4 stabilizers: potential cancer prevention and therapy-a critical review.
Choudhury SD; Kumar P; Choudhury D
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3585-3616. PubMed ID: 38019298
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone A induces cell cycle arrest and apoptosis via suppressing MAPK signaling pathway and the expression of FBXO5 in lung squamous cell cancer.
Fan X; Guan G; Wang J; Jin M; Wang L; Duan X
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859622
[TBL] [Abstract][Full Text] [Related]
20. Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.
Olloquequi J; Ettcheto M; Cano A; Fortuna A; Bicker J; Sánchez-Lopez E; Paz C; Ureña J; Verdaguer E; Auladell C; Camins A
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
